Home/Filings/4/0001169232-05-004237
4//SEC Filing

AEROGEN INC 4

Accession 0001169232-05-004237

CIK 0001039160operating

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 9:53 AM ET

Size

49.6 KB

Accession

0001169232-05-004237

Insider Transaction Report

Form 4
Period: 2005-07-28
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-07-28$0.65/sh33,700$21,817851,434 total(indirect: See footnote)
Footnotes (2)
  • [F1]The reported sale of 33,700 shares of the Issuer was made on behalf of the accounts of ProMed Partners, L.P., whose general partner is ProMed Asset Management, L.L.C. ("ProMed Asset Management"), which is controlled by David B. Musket and Barry Kurokawa (sold 6,000 shares and which as of the date of this Form 4, owns 449,480 shares of the Issuer); ProMed Partners II, L.P., whose general partner is also ProMed Asset Management (sold 1,650 shares and which as of the date of this Form 4, owns 82,336 shares of the Issuer); ProMed Offshore II Fund, Ltd., the Investment Manager of which is ProMed Management, Inc. ("ProMed Management") (sold 25,050 shares and which as of the date of this Form 4, owns 124,579 shares of the Issuer); and ProMed Offshore Fund, Ltd., whose investment manager is also ProMed Management (sold 1,000 shares and which as of the date of this Form 4, owns 72,564 shares of the Issuer). ProMed Management is controlled by David B. Musket and Barry Kurokawa.
  • [F2]The remainder of the reported amount of securities beneficially owned following the reported transaction may be deemed to be beneficially owned as follows: (A) 120,942 shares of the Issuer owned directly by David B. Muskat; and (B) 1,533 shares of the Issuer owned directly by Barry Kurokawa. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

AEROGEN INC

CIK 0001039160

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001039160

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 9:53 AM ET
Size
49.6 KB